Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 250+10 mikrogram

Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 125+5 mikrogram

Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mundipharma a/s - fluticasonpropionat, formoterolfumarat dihydrat - inhalationsspray, suspension - 50+5 mikrogram

Uni Eropa - Dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - zoledronsyremonohydrat - hypercalcemia; fractures, bone; cancer - bisfosfonater - forebyggelse af skeletrelaterede hændelser (patologiske frakturer, rygkompression, stråling eller operation til knogle eller tumorinduceret hypercalcæmi) hos voksne patienter med avancerede maligniteter, der involverer knogle. behandling af voksne patienter med tumor-induceret hypercalcaemia (tih).

Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter holding b.v. - tranexamsyre - injektions-/infusionsvæske, opløsning - 100 mg/ml

Denmark - Dansk - SEGES Landbrug & Fødevarer

syngenta nordics a/s - carbendazim, thiram, cymoxanil, oxadixyl - pulver - 167 g/kg carbendazim ; 334 g/kg thiram ; 67 g/kg cymoxanil ; 167 g/kg oxadixyl

Denmark - Dansk - SEGES Landbrug & Fødevarer

syngenta nordics a/s - fludioxonil, cymoxanil, metalaxyl-m - vanddispergerbart granulat - 50 g/kg fludioxonil ; 100 g/kg cymoxanil ; 175 g/kg metalaxyl-m

Denmark - Dansk - SEGES Landbrug & Fødevarer

klarsø a/s - 2,4-d - flydende middel - 500 g/l 2,4-d

Uni Eropa - Dansk - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - tolvaptan - uheldig adh-syndrom - diuretika, - behandling af voksne patienter med hyponatriæmi, der er sekundær for syndrom med upassende antidiuretisk-hormonsekretion (siadh).

Uni Eropa - Dansk - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.